INFECCIONES BACTERIANAS

1. Arenas R. Dermatología. McGraw Hill, 1ª ed., 1987.
   
   
2. Barton LL, Friedman AD. Impétigo: a reassessment of etiology and therapy. Pediatr. Dermatol., 1987; 4:185.
   
   
3. Dahl M.V. Estrategies for the management of recurrent furunculosis. South Med J. 1987; 80: 352-56.
   
   
4. Dajani A.S. et al. Natural history of impetigo. II. Etiologic agents and bacterial interactions. J Clin Invest. 1972; 51: 28-63.
   
   
5. Freedberg I. et al. Fitzpatrick’s Dermatology in General Medicine. McGraw Hill, 5ª ed.,1999.
   
   
6. Goldatein B., Goldstein A. Practical Dermatology. Mosby, 2ªed., 1997.
   
   
7. Habif T. Clinical Dermatology. Mosby 3ªed., 1996.
   
   
8. Hedstrom SA. Recurrent staphyloccal furunculosis: bacterial findings and epidemiology in 100 cases. Scand J Infect Dis 1981; 13:115-119.
   
   
9. Jemec GBE. The sintomatology of hidradenitis supurative in human. Br J Dermatol10. Jemec GBE et al. The prevalence of hidradenitis supurative and it’s potential precursor lesions. JAAD 1996; 35:191.
   
   
10. Meislin HW et al. Cutaneous abscesses: anaerobic bacteriology and outpatient management. Ann Intern Med1977; 87: 145-149.
    
    
11. Saúl A. Lecciones de Dermatología. Méndez Cervantes ed., 10ª ed., 1983.

ENFERMEDADES VIRALES DE LA PIEL

1. Richman DD. Clinical Virology. New York, Churchill Livingstone, 1997.
   
   
2. Fields BN et al (eds): Fields Virology, 3rd ed New York, Lippincott-Raven, 1996.
   
   
3. Saúl A. Lecciones de Dermatología. Treceava Edición, México, D.F., Méndez Editores, S.A de C.V.
   
   
4. Keating M. Antiviral Agente for Non-Human Inmunodeficiency Virus Infections. Mayo Clin Proc 1999; 74(12): 1266-1283.
   
   
5. Gibson JJ et al. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Ocurrence and determinants of infection. J Infect Dis 1990; 162:306-12.
   
   
6. Johnson RE et al. A seroepidemiologic study of the prevalence of herpes simplex type 2 infection in the United States. N Engl J Med 1989;321:7-12.
   
   
7. Koutsky L. Underdiagnosis of Genital Herpes By Current Clinical and Viral Isolation Procedures. N Engl J Med 1992; 326:1533-9.
   
   
8. Mertz GJ et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
   
   
9. Corey L et al. Genital herpes virus infections: Clinical manifestations, course and complications. Ann Int Med 1983;98: 958-972.
   
   
10. Quinn TC et al. Human inmunodeficiency virus infection among patientes attending clinics for sexually transmitted diseases. N Engl J Med 1988;318: 197-202.
    
    
11. Simonsen JN et al. Human inmunodeficienciy virus infection among men with sexually transmitted diseases. N Engl J Med 1988;319: 274-278.
    
    
12. Goldstein LC et al. Monoclonal antibodies to herpes simplex viruses: Use in antigenic typing and rapid diagnosis. J Infect Dis 1982,147: 829-837.
    
    
13. Spruance Sl et al. Treatment of herpes simplex labialis with topical acyclovir in polyethilene glycol. J Infect Dis 1982;146: 85-90.
    
    
14. Corey er al. A trial of topical aciclovir genital herpes simplex virus infections. N Engl J Med 1982;306: 1313-1319.
    
    
15. Koutsky L. Underdiagnosis of Genital Herpes By Current Clinical And Viral Isolation Procedures. N Engl J Med 1992;326:1533-9.
    
    
16. Choo PW et al. The epidemiology of varicella and its complications. J infect Dis 1995; 172:706-711.
    
    
17. Asano Y et al. Severity of viremia and clinical findings in children with varicella. J Infect Dis 1990;161:1095-1098.
    
    
18. Weibel RE et al. Live attenuated varicella virus vaccine: Efficacy trial in healthy children. N Engl J Med 1984;310:1410-1424.
    
    
19. White CJ et al. Measles, mumps, rubella, and varicella combination vaccine: Safety and inmunogenecity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group. Clin Infect Dis 1997;24: 925.

VERRUGAS VIRALES

1. Jablonska S, Schwartz RA. Warts. En: Demis DJ, ed. Clinical Dermatology. Philadelphia: Lippincott-Raven, 1996:14-14.
   
   
2. Lowy DR, Androphy EJ. Warts. En: Fitzpatrick’s Dermatology in General Medicine, New York: Mc Graw-Hill, 1999: 2484-97.
   
   
3. Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990;22:547-66.
   
   
4. Androphy EJ. Human papillomavirus: current concepts. Arch Dermatol 1989;125:683-85.
5. Brown TJ, Yen-Moore A, Tyring SK. An overview of sexually transmitted diseases. Part II. J Am Acad Dermatol 1999;41:661-77.
6. Greene I.Therapy for genital warts. Dermatol Clin 1992;10:253-67.
7. Heaton CL. Clinical manifestations and modern management of condyloma acuminata: a dermatologic perspective. Am J Obstet Gnecol 1995;172:1344-50.
8. Ling MR. Therapy of genital human papillomavirus infections. Part I. Indications for and justification of therapy. Int J Dermatol 1992;31:682-86.
9. Ling MR. Therapy of human papillomavirus infections. Part II. Methods of treatment. Int J Dermatol 1992;31: 769-76.
10. Bashi, SA. Cryotherapy versus podophyllin in the treatment of genital warts. Int J Dermatol 1985;24:535-36.
11. Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998;38:230-9.
12. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997;36:659-85.

Molusco contagioso

1. Diven DG, Raimer SS. Molluscum contagiosum. En: Demis DJ, ed. Clinical Dermatology. Philadelphia: Lippincott-Raven, 1996:14-13.
2. Lowy DR. Molluscum contagiosum. En: Fitzpatrick’s Dermatology In General Medicine. New York: Mc Graw-Hill, 1999:2478-81.
3. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol 1993;33:453-61.
4. Porter CD, Blake NW, Archard LC, et al. Molluscum contagiosum virus types in genital and non-genital lesions. Br. J Dermatol 1989; 120:37-41.
5. Brown T, Yen-Moore A, Tyring S. An overview of sexually transmitted diseases. Part II. J Am Acad Dermatol 1999;41:661-77.
6. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol 1992;27:583-88.
7. Coldiron BM, Bergstrasser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989;125:357-61.
8. Lewis EJ, Lam M, Crutchfield CE III. An update on molluscum contagiosum. Cutis 1997;60:29-34

Tuberculosis de la piel

1. Aceves Ortega R. Tuberculosis Cutánea. Actas Fac. Medicina. 1986:6; 150-166.
2. Betsué M. Cordero A. Y Casas G. Lupus Vulgar. A propósito de un caso. Act. Terap. Dermatol. 2000;23:44-49.
3. Grange Jm. Mycobacteria and the skin. Int. Jour. Dermatol. 1982: 21;497-503.
4. Lever, Schamburg-Lever. Histopathology of the skin. 7th. Edition. Lippincott Company. Philadelphia. 1990, pp. 326-332.
5. Pautrier Lm. Tuberculose Cutanée. Nouvelle Practique Dermatologique. Paris, Masson. et. Cie. 1936. Tomo III, 363-672.
6. Pautrier Lm. Et Woringer Fr. Tuberculides micronodulares de la face, du cou et de la Poitrine. Bull. Soc. Franç. Dermat. 1938:45; 121-129.
7. Palangié A. Et Wallach D. Tuberculose Cutanée. Encycl. Med. Chir. Paris. Dermatologie, 12510 A10, 10-1981.
8. Rodríguez O. Tuberculosis Cutánea. Rev. Centro Dermat. Pascua. 1993: 2;53-64.
9. Rodríguez O. Tuberculosis Diseminada. Rev. Centro Dermat. Pascua. 1994: 3;6-14.
10. Saúl A. Enfermedades Producidas por Micobacterias. Tuberculosis Cutánea. Lecciones de Dermatología. Decimotercera Edición. 1993. Editorial Méndez Editores, S.A. de C.V. pp. 72-84.
11. Schneider M., Jordaan Hf., Geiger Dh. et Al. Erythema Induratum of Bazin. A Clinicopathological Study of 20 cases and Detection of Mycobacterium. Tuberculosis DNA in Skin Lesions by Polymerase Chain Reaction. Amer. Jour. Dermatopath. 1995: 17(4);350-356.
12. Villa Soto Kc., Esquivel Le, Y López R. Tuberculosis. Una Luna Menguante. Ciencia Médica Boletín de la División de Estudios de Posgrado e Investigación de la Facultad de Medicina. U.N.A.M. 1995: 1(4);10-16.

Lepra

1. Bechelli LM, Rotberg A, Maurano F. Clínica e terapéutica. Tratado de Leprología. Vol. 4, Río de Janeiro. Servicio Nacional de Lepra, 1944.
2. Browne SG, Hogerzeil LM. "B663" in the treatment of leprosy. Preliminary Report of a pilot trial. Lepr Rev. 1962;33:6-10.
3. Bryceson A, Pfaltzgraff RE. Leprosy for Students of Medicine.Edinburgh: Churchill Livingstone, 1973.
4. Contreras F, Miquel SF. Historia de la Lepra en España. Madrid: Gráficas Hergón, S.L., 1973.
5. De Castro J. Manual de Leprología. Publicado de Servico Nacional de Lepra.Río de Janeiro: Empresa Grafica dos Tribunais, 1960.
6. Faget GH, Pogge RC, Johansen FA, Dinan JF, Prejean BM. El tratamiento de la lepra co n Promín. Pub Health Rep. 1943:58:1729-1736.
7. González Urueña J. La Lepra en México. Buenos Aires: El Ateneo, 1941.
8. Latapí F. Lepra y Leprosos. Gac Méd de México. 1944;74:182.
9. Latapí F. Clasificación de la Lepra (Tipo, grupo, forma y caso). Memorias del V Congreso Internacional de la Lepra. La Habana, Cuba 1948. Editorial Cenit, 1949. pp. 461-487.
10. Latapí F, Chévez A.The "Spotted" Leprosy of Lucio. Int J Leprosy. 1948;16:421-428.
11. Lowe J. Treatment of Leprosy with diamino-diphenil-sulphone by mouth. Lancet. 1950;1:145-150.
12. Novales J. II. Aspectos histopatológicos de la Lepra de Lucio. Dermatología Rv Mex. 1978;164-174.
13. Novales J. Lucio’s Leprosy. Histopathological aspects. Amsterdam Excerpta Medica. 1979, pp.205-212.
14. Opromolla DVA. Primeros resultados de la rifampicina S.V. en la lepra lepromatosa. Memorias del VIII Congreso Internacional de Leprologia. Río de Janeiro. 1963;39-41.
15. Ridley DS, Jopling WH. Classification of leprosy. According to immunity. A five Group System. Int J Leprosy 1966;34:255-273.
16. Rodríguez O. La lepra y los Niños. Tesis. Mexico, D.F. 1949.
17. Rodríguez O. Lepra de Lucio. Rev. Med. Estud.gen. Navarra. 1958;2:304.
18. Rodríguez O. Lepra de Lucio. Memorias del III Congreso Ibero Latino Americano de Dermatología. México: Unión Gráfica Mexicana, 1959: pp. 297-301.
19. Rodríguez, O. Lepra de Lucio. I Historia y concepto. Dermatología Rev Mex. 1978;22:117-140.
20. Rodríguez O. Tratamiento de la Lepra. Dermatología Rv Mex.l987;31:29-33.
21. Rodríguez O. Lepra. Clasificación y Terminología. Rev C Dermatol Pascua 1992;1:27-33.
22. Saúl A. Lecciones de Dermatología. 13ª. Edición México. Méndez Cervantes,1993:85-137.
23. Saúl A,.Manifestaciones agudas de la lepra. Dermatología RvMex 1989;4: 256-261.
24. Sheskin J. Thalidomide in the treatment of lepra reaction. Clin Pharm Ther 1965;6:303-306.
25. Terencio de las Aguas J. Lecciones de Leprología.Fontilles: De Domenech,1973.
26. Terencio de las Aguas J. La Lepra. Pasado, Presente y Futuro.Valencia: Generalitat Valenciana, 1999.
27. Wade HV. Tuberculoid changes in leprosy. II Lepra reaction in tuberculoid leprosy. Int J Leprosy1934;2:279-292.
28. Wade HV, Rodríguez JN. Borderline tuberculoid leprosy. Int J Leprosy 1940.;8:307-332.

Dermatosis por micobacterias atÍpicas

1. Adams RM, Remington JS and Steinberg J et al. Tropical fish aquariums. A source of Mycobacterium marinum infections resembling sporotrichosis J.A.M.A. 1970; 211: 457-461.
2. Arenas R, Vega ME, Hojyo TT y cols. Micobacteriosis atípicas. Aspectos clínico-epidemiológicos de 44 casos. Dermatol Rev Mex 1993;37: 305-315.
3. Barker DJ. Mycobacterial skin ulcers. Br J Dermatol 1974;91:473-474.
4. Brock Jm, Kennedy CB and WH. Cutaneos infection with atypical mycobacterium Arch Dermatol 1960: 120-122.
5. Cañizares O. Clinical Tropical Dermatology. Lavalle P and Novales J. Other Mycobacteria. First edition 1975: 215-222.
6. Connor DH, Lunn F et al. Buruli Ulceration. A clinicopathologic study of 38 Ugandans with Mycobacterium ulcerans ulceration Arch. Path 1966;81:183-199.
7. Grange JM. Mycobacteria and the skin Int J dermatol 1982;21:497-503.
8. Grange JM. Enfermedades Micobacterianas. Editorial Científica. 1985.
9. Grange JM. Infection and disease due to the environmental mycobacteria. Trans R Soc Trop Med Hyg 1987; 81:179-182.
10. Hautmann G and Lotti T. Atipical Mycobacterial infections of the skin. Dermatologic clinics 1994; 12:657-668.
11. Hirsh FS and Saffold OE. Mycobacterium kansasii Infection with Dermatologic Manifestations. Arch Dermatol 1976;112:706-708.
12. Iribe P. Micobacteriosis Cutánea Ulcerosa por Mycobacterium ulcerans. Estudio de dos casos. Tesis de Posgrado en Dermatología. C.D.P. 1999.
13. Iribe P. Glanuloma de las Piscinas. Estudio de seis casos. Tesis de Posgrado en Dermatopatología. C.D.P. 2000.
14. Knox JM, Gever SG and Freeman RG et al. Atypical acid fast organism infection of the skin Arch Dermatol 1961;84:386-391.
15. Lavalle AP et al. Un caso de infección humana por Mycobacterium ulcerans en el Hemisferio Occidental (Nota Previa). Memorias VI Congreso Internacional Leprología, Madrid, Octubre 1953: 697-706.
16. Lavalle AP et al. Un caso de infección humana por Mycobacterium ulcerans en el Hemisferio Occidental. Nota Previa. Int J Lepr 1953; 21: 469-476.
17. Lavalle AP et al. Infección humana por Mycobacterium ulcerans. Dermatol Rev Mex 1956; 1: 5-15.
18. Lavalle P, Ovando F, Novales J et al. Mycobacteriosis Cutánea Ulcerosa. Dermatol Rev Mex 1981; XXV: 325-347.
19. MacCallum. A new mycobaterial infection in man. Clinical aspects. J Path Bact 1948; LX: 93-101.
20. Meyers WM, Connor DH et al. Distribution of Mycobacterium ulcerans infections in Zayre, including the report of new foci. Ann Soc Belgue Med Trop 1974;54: 147-157.
21. Mollohan CS and Romer RS. Public health significance of swimming pool granuloma Am J Public Health 1961;51:883-891.
22. Owens DW and Mc bride ME. Sporotrichoid Cutaneous Infection with Mycobacterium kansasii. Arch Derm 1969;100:54-58.
23. Schaefer WB and Davis CL. A bacteriologic and histopathologic study of skin granuloma due to Mycobacterium balnei Am Rev Resp Dis 1961;84: 837-844.
24. Scholssberg D. Tuberculosis and Nontuberculous Mycobacterial Infections. Fourth Edition. W.B. Saunders Company. 1999.
25. Sirimachan S and Bhuddhavudhikrai P Mycobacterium marinum cutaneous infections acquired from ocupations and hobbies. Int J Dermatol 1993;32:504-507.
26. Sowers WF. Swimming pool granuloma due to Mycobacterium scrofulaceum Arch Dermatol 1972;105:760- 761.
27. Street M, Umbert-Millet and Roberts Gd et al. Nontuberculous mycobacterial infections of the skin. Report fourteen cases and review of the literature J Am Acad Dermatol 1991;24:208-215.
28. Tolmach JA and Frank SB. Granuloma of skin with tubercle formation following swimming pool injury J. A. M. A. 1953;151: 724-726.
29. Van Oye et Ballion M Faudra-t-il tenir compte dúne nouvelle afection a bacieles acido résistans en Afrique. Ann Soc Belgue Med Trop 1950;30: 619-621.

1. Arenas R. Dermatología. McGraw Hill, 1ª ed., 1987. 2. Barton LL, Friedman AD. Impétigo: a reassessment of etiology and therapy. Pediatr. Dermatol., 1987; 4:185. 3. Dahl M.V. Estrategies for the management of recurrent furunculosis. South Med J. 1987; 80: 352-56. 4. Dajani A.S. et al. Natural history of impetigo. II. Etiologic agents and bacterial interactions. J Clin Invest. 1972; 51: 28-63. 5. Freedberg I. et al. Fitzpatrick’s Dermatology in General Medicine. McGraw Hill, 5ª ed.,1999. 6. Goldatein B., Goldstein A. Practical Dermatology. Mosby, 2ªed., 1997. 7. Habif T. Clinical Dermatology. Mosby 3ªed., 1996. 8. Hedstrom SA. Recurrent staphyloccal furunculosis: bacterial findings and epidemiology in 100 cases. Scand J Infect Dis 1981; 13:115-119. 9. Jemec GBE. The sintomatology of hidradenitis supurative in human. Br J Dermatol10. Jemec GBE et al. The prevalence of hidradenitis supurative and it’s potential precursor lesions. JAAD 1996; 35:191. 11. Meislin HW et al. Cutaneous abscesses: anaerobic bacteriology and outpatient management. Ann Intern Med1977; 87: 145-149. 12. Saúl A. Lecciones de Dermatología. Méndez Cervantes ed., 10ª ed., 1983. Enfermedades virales de la piel 1. Richman DD. Clinical Virology. New York, Churchill Livingstone, 1997. 2. Fields BN et al (eds): Fields Virology, 3rd ed New York, Lippincott-Raven, 1996. 3. Saúl A. Lecciones de Dermatología. Treceava Edición, México, D.F., Méndez Editores, S.A de C.V. 4. Keating M. Antiviral Agente for Non-Human Inmunodeficiency Virus Infections. Mayo Clin Proc 1999; 74(12): 1266-1283. 5. Gibson JJ et al. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: Ocurrence and determinants of infection. J Infect Dis 1990; 162:306-12. 6. Johnson RE et al. A seroepidemiologic study of the prevalence of herpes simplex type 2 infection in the United States. N Engl J Med 1989;321:7-12. 7. Koutsky L. Underdiagnosis of Genital Herpes By Current Clinical and Viral Isolation Procedures. N Engl J Med 1992; 326:1533-9. 8. Mertz GJ et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202. 9. Corey L et al. Genital herpes virus infections: Clinical manifestations, course and complications. Ann Int Med 1983;98: 958-972. 10. Quinn TC et al. Human inmunodeficiency virus infection among patientes attending clinics for sexually transmitted diseases. N Engl J Med 1988;318: 197-202. 11. Simonsen JN et al. Human inmunodeficienciy virus infection among men with sexually transmitted diseases. N Engl J Med 1988;319: 274-278. 12. Goldstein LC et al. Monoclonal antibodies to herpes simplex viruses: Use in antigenic typing and rapid diagnosis. J Infect Dis 1982,147: 829-837. 13. Spruance Sl et al. Treatment of herpes simplex labialis with topical acyclovir in polyethilene glycol. J Infect Dis 1982;146: 85-90. 14. Corey er al. A trial of topical aciclovir genital herpes simplex virus infections. N Engl J Med 1982;306: 1313-1319. 15. Koutsky L. Underdiagnosis of Genital Herpes By Current Clinical And Viral Isolation Procedures. N Engl J Med 1992;326:1533-9. 16. Choo PW et al. The epidemiology of varicella and its complications. J infect Dis 1995; 172:706-711. 17. Asano Y et al. Severity of viremia and clinical findings in children with varicella. J Infect Dis 1990;161:1095-1098. 18. Weibel RE et al. Live attenuated varicella virus vaccine: Efficacy trial in healthy children. N Engl J Med 1984;310:1410-1424. 19. White CJ et al. Measles, mumps, rubella, and varicella combination vaccine: Safety and inmunogenecity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group. Clin Infect Dis 1997;24: 925. Verrugas virales 1. Jablonska S, Schwartz RA. Warts. En: Demis DJ, ed. Clinical Dermatology. Philadelphia: Lippincott-Raven, 1996:14-14. 2. Lowy DR, Androphy EJ. Warts. En: Fitzpatrick’s Dermatology in General Medicine, New York: Mc Graw-Hill, 1999: 2484-97. 3. Cobb MW. Human papillomavirus infection. J Am Acad Dermatol 1990;22:547-66. 4. Androphy EJ. Human papillomavirus: current concepts. Arch Dermatol 1989;125:683-85. 5. Brown TJ, Yen-Moore A, Tyring SK. An overview of sexually transmitted diseases. Part II. J Am Acad Dermatol 1999;41:661-77. 6. Greene I.Therapy for genital warts. Dermatol Clin 1992;10:253-67. 7. Heaton CL. Clinical manifestations and modern management of condyloma acuminata: a dermatologic perspective. Am J Obstet Gnecol 1995;172:1344-50. 8. Ling MR. Therapy of genital human papillomavirus infections. Part I. Indications for and justification of therapy. Int J Dermatol 1992;31:682-86. 9. Ling MR. Therapy of human papillomavirus infections. Part II. Methods of treatment. Int J Dermatol 1992;31: 769-76. 10. Bashi, SA. Cryotherapy versus podophyllin in the treatment of genital warts. Int J Dermatol 1985;24:535-36. 11. Beutner KR, Spruance SL, Hougham AJ, et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998;38:230-9. 12. Majewski S, Jablonska S. Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol 1997;36:659-85. Molusco contagioso 1. Diven DG, Raimer SS. Molluscum contagiosum. En: Demis DJ, ed. Clinical Dermatology. Philadelphia: Lippincott-Raven, 1996:14-13. 2. Lowy DR. Molluscum contagiosum. En: Fitzpatrick’s Dermatology In General Medicine. New York: Mc Graw-Hill, 1999:2478-81. 3. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J Dermatol 1993;33:453-61. 4. Porter CD, Blake NW, Archard LC, et al. Molluscum contagiosum virus types in genital and non-genital lesions. Br. J Dermatol 1989; 120:37-41. 5. Brown T, Yen-Moore A, Tyring S. An overview of sexually transmitted diseases. Part II. J Am Acad Dermatol 1999;41:661-77. 6. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol 1992;27:583-88. 7. Coldiron BM, Bergstrasser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1989;125:357-61. 8. Lewis EJ, Lam M, Crutchfield CE III. An update on molluscum contagiosum. Cutis 1997;60:29-34 Tuberculosis de la piel 1. Aceves Ortega R. Tuberculosis Cutánea. Actas Fac. Medicina. 1986:6; 150-166. 2. Betsué M. Cordero A. Y Casas G. Lupus Vulgar. A propósito de un caso. Act. Terap. Dermatol. 2000;23:44-49. 3. Grange Jm. Mycobacteria and the skin. Int. Jour. Dermatol. 1982: 21;497-503. 4. Lever, Schamburg-Lever. Histopathology of the skin. 7th. Edition. Lippincott Company. Philadelphia. 1990, pp. 326-332. 5. Pautrier Lm. Tuberculose Cutanée. Nouvelle Practique Dermatologique. Paris, Masson. et. Cie. 1936. Tomo III, 363-672. 6. Pautrier Lm. Et Woringer Fr. Tuberculides micronodulares de la face, du cou et de la Poitrine. Bull. Soc. Franç. Dermat. 1938:45; 121-129. 7. Palangié A. Et Wallach D. Tuberculose Cutanée. Encycl. Med. Chir. Paris. Dermatologie, 12510 A10, 10-1981. 8. Rodríguez O. Tuberculosis Cutánea. Rev. Centro Dermat. Pascua. 1993: 2;53-64. 9. Rodríguez O. Tuberculosis Diseminada. Rev. Centro Dermat. Pascua. 1994: 3;6-14. 10. Saúl A. Enfermedades Producidas por Micobacterias. Tuberculosis Cutánea. Lecciones de Dermatología. Decimotercera Edición. 1993. Editorial Méndez Editores, S.A. de C.V. pp. 72-84. 11. Schneider M., Jordaan Hf., Geiger Dh. et Al. Erythema Induratum of Bazin. A Clinicopathological Study of 20 cases and Detection of Mycobacterium. Tuberculosis DNA in Skin Lesions by Polymerase Chain Reaction. Amer. Jour. Dermatopath. 1995: 17(4);350-356. 12. Villa Soto Kc., Esquivel Le, Y López R. Tuberculosis. Una Luna Menguante. Ciencia Médica Boletín de la División de Estudios de Posgrado e Investigación de la Facultad de Medicina. U.N.A.M. 1995: 1(4);10-16. Lepra 1. Bechelli LM, Rotberg A, Maurano F. Clínica e terapéutica. Tratado de Leprología. Vol. 4, Río de Janeiro. Servicio Nacional de Lepra, 1944. 2. Browne SG, Hogerzeil LM. “B663” in the treatment of leprosy. Preliminary Report of a pilot trial. Lepr Rev. 1962;33:6-10. 3. Bryceson A, Pfaltzgraff RE. Leprosy for Students of Medicine.Edinburgh: Churchill Livingstone, 1973. 4. Contreras F, Miquel SF. Historia de la Lepra en España. Madrid: Gráficas Hergón, S.L., 1973. 5. De Castro J. Manual de Leprología. Publicado de Servico Nacional de Lepra.Río de Janeiro: Empresa Grafica dos Tribunais, 1960. 6. Faget GH, Pogge RC, Johansen FA, Dinan JF, Prejean BM. El tratamiento de la lepra co n Promín. Pub Health Rep. 1943:58:1729-1736. 7. González Urueña J. La Lepra en México. Buenos Aires: El Ateneo, 1941. 8. Latapí F. Lepra y Leprosos. Gac Méd de México. 1944;74:182. 9. Latapí F. Clasificación de la Lepra (Tipo, grupo, forma y caso). Memorias del V Congreso Internacional de la Lepra. La Habana, Cuba 1948. Editorial Cenit, 1949. pp. 461-487. 10. Latapí F, Chévez A.The “Spotted” Leprosy of Lucio. Int J Leprosy. 1948;16:421-428. 11. Lowe J. Treatment of Leprosy with diamino-diphenil-sulphone by mouth. Lancet. 1950;1:145-150. 12. Novales J. II. Aspectos histopatológicos de la Lepra de Lucio. Dermatología Rv Mex. 1978;164-174. 13. Novales J. Lucio’s Leprosy. Histopathological aspects. Amsterdam Excerpta Medica. 1979, pp.205-212. 14. Opromolla DVA. Primeros resultados de la rifampicina S.V. en la lepra lepromatosa. Memorias del VIII Congreso Internacional de Leprologia. Río de Janeiro. 1963;39-41. 15. Ridley DS, Jopling WH. Classification of leprosy. According to immunity. A five Group System. Int J Leprosy 1966;34:255-273. 16. Rodríguez O. La lepra y los Niños. Tesis. Mexico, D.F. 1949. 17. Rodríguez O. Lepra de Lucio. Rev. Med. Estud.gen. Navarra. 1958;2:304. 18. Rodríguez O. Lepra de Lucio. Memorias del III Congreso Ibero Latino Americano de Dermatología. México: Unión Gráfica Mexicana, 1959: pp. 297-301. 19. Rodríguez, O. Lepra de Lucio. I Historia y concepto. Dermatología Rev Mex. 1978;22:117-140. 20. Rodríguez O. Tratamiento de la Lepra. Dermatología Rv Mex.l987;31:29-33. 21. Rodríguez O. Lepra. Clasificación y Terminología. Rev C Dermatol Pascua 1992;1:27-33. 22. Saúl A. Lecciones de Dermatología. 13ª. Edición México. Méndez Cervantes,1993:85-137. 23. Saúl A,.Manifestaciones agudas de la lepra. Dermatología RvMex 1989;4: 256-261. 24. Sheskin J. Thalidomide in the treatment of lepra reaction. Clin Pharm Ther 1965;6:303-306. 25. Terencio de las Aguas J. Lecciones de Leprología.Fontilles: De Domenech,1973. 26. Terencio de las Aguas J. La Lepra. Pasado, Presente y Futuro.Valencia: Generalitat Valenciana, 1999. 27. Wade HV. Tuberculoid changes in leprosy. II Lepra reaction in tuberculoid leprosy. Int J Leprosy1934;2:279-292. 28. Wade HV, Rodríguez JN. Borderline tuberculoid leprosy. Int J Leprosy 1940.;8:307-332. Dermatosis por micobacterias atÍpicas 1. Adams RM, Remington JS and Steinberg J et al. Tropical fish aquariums. A source of Mycobacterium marinum infections resembling sporotrichosis J.A.M.A. 1970; 211: 457-461. 2. Arenas R, Vega ME, Hojyo TT y cols. Micobacteriosis atípicas. Aspectos clínico-epidemiológicos de 44 casos. Dermatol Rev Mex 1993;37: 305-315. 3. Barker DJ. Mycobacterial skin ulcers. Br J Dermatol 1974;91:473-474. 4. Brock Jm, Kennedy CB and WH. Cutaneos infection with atypical mycobacterium Arch Dermatol 1960: 120-122. 5. Cañizares O. Clinical Tropical Dermatology. Lavalle P and Novales J. Other Mycobacteria. First edition 1975: 215-222. 6. Connor DH, Lunn F et al. Buruli Ulceration. A clinicopathologic study of 38 Ugandans with Mycobacterium ulcerans ulceration Arch. Path 1966;81:183-199. 7. Grange JM. Mycobacteria and the skin Int J dermatol 1982;21:497-503. 8. Grange JM. Enfermedades Micobacterianas. Editorial Científica. 1985. 9. Grange JM. Infection and disease due to the environmental mycobacteria. Trans R Soc Trop Med Hyg 1987; 81:179-182. 10. Hautmann G and Lotti T. Atipical Mycobacterial infections of the skin. Dermatologic clinics 1994; 12:657-668. 11. Hirsh FS and Saffold OE. Mycobacterium kansasii Infection with Dermatologic Manifestations. Arch Dermatol 1976;112:706-708. 12. Iribe P. Micobacteriosis Cutánea Ulcerosa por Mycobacterium ulcerans. Estudio de dos casos. Tesis de Posgrado en Dermatología. C.D.P. 1999. 13. Iribe P. Glanuloma de las Piscinas. Estudio de seis casos. Tesis de Posgrado en Dermatopatología. C.D.P. 2000. 14. Knox JM, Gever SG and Freeman RG et al. Atypical acid fast organism infection of the skin Arch Dermatol 1961;84:386-391. 15. Lavalle AP et al. Un caso de infección humana por Mycobacterium ulcerans en el Hemisferio Occidental (Nota Previa). Memorias VI Congreso Internacional Leprología, Madrid, Octubre 1953: 697-706. 16. Lavalle AP et al. Un caso de infección humana por Mycobacterium ulcerans en el Hemisferio Occidental. Nota Previa. Int J Lepr 1953; 21: 469-476. 17. Lavalle AP et al. Infección humana por Mycobacterium ulcerans. Dermatol Rev Mex 1956; 1: 5-15. 18. Lavalle P, Ovando F, Novales J et al. Mycobacteriosis Cutánea Ulcerosa. Dermatol Rev Mex 1981; XXV: 325-347. 19. MacCallum. A new mycobaterial infection in man. Clinical aspects. J Path Bact 1948; LX: 93-101. 20. Meyers WM, Connor DH et al. Distribution of Mycobacterium ulcerans infections in Zayre, including the report of new foci. Ann Soc Belgue Med Trop 1974;54: 147-157. 21. Mollohan CS and Romer RS. Public health significance of swimming pool granuloma Am J Public Health 1961;51:883-891. 22. Owens DW and Mc bride ME. Sporotrichoid Cutaneous Infection with Mycobacterium kansasii. Arch Derm 1969;100:54-58. 23. Schaefer WB and Davis CL. A bacteriologic and histopathologic study of skin granuloma due to Mycobacterium balnei Am Rev Resp Dis 1961;84: 837-844. 24. Scholssberg D. Tuberculosis and Nontuberculous Mycobacterial Infections. Fourth Edition. W.B. Saunders Company. 1999. 25. Sirimachan S and Bhuddhavudhikrai P Mycobacterium marinum cutaneous infections acquired from ocupations and hobbies. Int J Dermatol 1993;32:504-507. 26. Sowers WF. Swimming pool granuloma due to Mycobacterium scrofulaceum Arch Dermatol 1972;105:760- 761. 27. Street M, Umbert-Millet and Roberts Gd et al. Nontuberculous mycobacterial infections of the skin. Report fourteen cases and review of the literature J Am Acad Dermatol 1991;24:208-215. 28. Tolmach JA and Frank SB. Granuloma of skin with tubercle formation following swimming pool injury J. A. M. A. 1953;151: 724-726. 29. Van Oye et Ballion M Faudra-t-il tenir compte dúne nouvelle afection a bacieles acido résistans en Afrique. Ann Soc Belgue Med Trop 1950;30: 619-621.